Health systems around the world seek to address patients’ unmet health needs for a range of acute and chronic diseases. Simultaneously, governments strive to keep healthcare spending sustainable, while providing equal access to high-quality care. This has fuelled debate around what constitutes a valuable healthcare intervention in a health system and the corollary consideration of what governments are willing to pay for a certain health intervention. Until recently, the value of information in general, and the value of diagnostic information (VODI) specifically, was not part of the discussion.However, investment in diagnostic information can be a key development as information may guide more effective and efficient healthcare and help maintain an affordable health system. This paper therefore explores ways to best define, evaluate, and reward the value created from diagnostics in healthcare and how to include these value considerations in decision-making processes for diagnostics. The authors ultimately call for a holistic VODI framework that accounts for the full range of potential benefits of diagnostic testing, beyond the traditional clinical and health economic domains, and that is essential to recognise, measure, and fully leverage the benefits of diagnostics for patients, health systems, and society.

1.
OECD
.
Health at a Glance
.
Europe
.
2016
.0014-2751
2.
Porter
ME
.
What is value in health care?
N Engl J Med
.
2010
Dec
;
363
(
26
):
2477
81
.
[PubMed]
0028-4793
3.
Oortwijn
W
,
Sampietro-Colom
L
,
Habens
F
.
Developments in value frameworks to inform the allocation of healthcare resources
.
Int J Technol Assess Health Care
.
2017
Jan
;
33
(
2
):
323
9
.
[PubMed]
0266-4623
4.
The Lewin Group, Inc.
The value of diagnostics innovation, adoption and diffusion into health care
;
2005
. Available: http://www.lewin.com/~/media/Lewin/Site_Sections/Publications/ValueofDiagnostics.pdf
5.
MedTech Europe. The European Medical Technology Industry – in figures /
2018
. Available: http://www.medtecheurope.org/sites/default/files/resource_items/files/MedTech%20Europe_FactsFigures2018_FINAL_0.pdf
6.
Asch
DA
,
Patton
JP
,
Hershey
JC
.
Knowing for the sake of knowing: the value of prognostic information
.
Med Decis Making
.
1990
Jan-Mar
;
10
(
1
):
47
57
.
[PubMed]
0272-989X
7.
Andrea Anonychuk
, MSc, Graham Beastall, PhD, FRCP, Simon Shorter, PhD, Regina Kloss-Wolf, Peter Neumann, ScD. A Framework for Assessing the Value of Laboratory Diagnostic. Healthcare Management Forum first published
2012
. Vol 25, Issue 3_suppl, pp. S4 - S11
8.
Merlin
T
,
Farah
C
,
Schubert
C
,
Mitchell
A
,
Hiller
JE
and
Ryan
P
.
Assessing Personalized Medicines in Australia: A National Framework for Reviewing Codependent Technologies.
Med Decis Making
2013
33: 333 originally published online 15 August 2012 DOI:
9.
Garau
M
.
Can and should value based pricing be applied to molecular diagnostics?
OHE. Research paper
2012
.
10.
Garrison
L
,
Rejon-Parrilla
JC
,
Mestre-Ferrandiz
J
.
Value of diagnostic information concept.
Presented at the
VODI Platform kick off meeting
,
Brussels
,12 June
2015
.
11.
Garrison
L
,
Mestre-Ferrandiz
J
,
Zamora
B
.
The Value of Knowing and Knowing the Value: Improving the Health Technology Assessment of Complementary Diagnostics
.
London, UK
:
Office of Health Economics
;
2016
.
12.
Paulsen
JS
,
Nance
M
,
Kim
JI
,
Carlozzi
NE
,
Panegyres
PK
,
Erwin
C
, et al.
A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases
.
Prog Neurobiol
.
2013
Nov
;
110
:
2
28
.
[PubMed]
0301-0082
13.
Akhmetov
I
,
Bubnov
RV
.
Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine
.
EPMA J
.
2015
Sep
;
6
(
1
):
19
.
[PubMed]
1878-5077
14.
Wurcel
V
, et al.
 Medical Technologies: Involving Patients in Development and Assessment.
Facey et al. Patient involvement in Health Technology Assessment
.
Springer
;
2017
.
15.
Taylor
CA
,
Myers
RH
.
Long-term impact of Huntington disease linkage testing
.
Am J Med Genet
.
1997
Jun
;
70
(
4
):
365
70
.
[PubMed]
0148-7299
16.
Almqvist
EW
,
Bloch
M
,
Brinkman
R
,
Craufurd
D
,
Hayden
MR
.
A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease
.
Am J Hum Genet
.
1999
May
;
64
(
5
):
1293
304
.
[PubMed]
0002-9297
17.
National Institute for Public Health and the Environment
.
Social cost-benefit analysis of regulatory policies to reduce alcohol use in The Netherlands
.
Bilthoven
;
2016
. p.
137
.
18.
Garrison
LP
 Jr
,
Neumann
PJ
,
Willke
RJ
,
Basu
A
,
Danzon
PM
,
Doshi
JA
, et al.
A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]
.
[7]
.
Value Health
.
2018
Feb
;
21
(
2
):
161
5
.
[PubMed]
1098-3015
19.
Peter
J
.
Neumann, ScD, Richard J. Willke, PhD, Louis P. Garrison Jr, PhD. A Health Economics Approach to US Value Assessment Frameworks—Introduction: An ISPOR Special Task Force Report
.
Value Health
.
2018
Feb
;
21
(
2
):
119
23
.
[PubMed]
1098-3015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.